Loading the section…
The price of Corvus Pharmaceuticals, Inc. (CRVS) on October 9, 2026 is 10.52 USD, +3.04% on the day. Over 52 weeks the stock traded between 6.39 USD and 26.95 USD; the price now sits 20% of the way up that range. Over the past year the price changed by +50.29%. Market capitalization is 303.35 million USD, rank 172 among 373 stocks of the same industry with a known capitalization.
Closing prices for 9 October 2026
Next earnings report: 3 November 2026 · Earnings calendar
Change over the period shown (line colour): +47.96 %
Corvus Pharmaceuticals, Inc. trades on Nasdaq under the ticker CRVS. The company belongs to the Health care sector. The trading history on this page starts on 22 August 2016.
Over the past 52 weeks CRVS has traded between 6.39 $ and 26.95 $. As of 9 October 2026 the price stood 20.09 % of the way from the 52-week low to the high.
Over one year CRVS shares rose 50.29 %; over six months they fell 30.33 %. Volatility over 90 days is 49.34 %. Dividends are not included: this is price change only, as of 9 October 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to book is 1.3, below the sector median of 2.5. Calculated from reports for the period ending 31 March 2026.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 9 October 2026 | 10.21 | 10.71 | 10.08 | 10.52 | 1M |
| 8 October 2026 | 10.15 | 10.31 | 9.82 | 10.21 | 2M |
| 7 October 2026 | 10.25 | 10.65 | 10.25 | 10.41 | 1M |
| 6 October 2026 | 10.75 | 10.96 |
The series is stated in the current share scale after splits; dividends are not included in the price
Based on the last 12 months of reports, through 31 March 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
No news about this security in English yet.
Address:901 GATEWAY BLVD, THIRD FLOOR, SOUTH SAN FRANCISCO, CA, 94080, US
CRVS has a return on equity of −18.35 %, above the sector median of −41.68 %. Return on assets is −17.44 %, above the sector median of −32.11 %.
| 1.2B |
| PFEPfizer, Inc. | 28.28 | +1.65 % | 922M |
| ABTAbbott Laboratories | 99.60 | +1.13 % | 921M |
| BMYBristol-Myers Squibb Company | 59.12 | −0.77 % | 714M |
| REGNRegeneron Pharmaceuticals, Inc. | 746.54 | +0.94 % | 555M |
| 10.20 |
| 10.56 |
| 1M |
| 5 October 2026 | 10.88 | 11.15 | 10.45 | 10.74 | 823,700 |
| 2 October 2026 | 11.11 | 11.11 | 10.64 | 10.90 | 1M |
| 1 October 2026 | 11.56 | 11.75 | 10.89 | 10.93 | 1M |
| 30 September 2026 | 12.00 | 12.03 | 11.50 | 11.52 | 875,700 |
| 29 September 2026 | 12.37 | 12.42 | 11.72 | 11.76 | 881,900 |
| 28 September 2026 | 11.66 | 12.12 | 11.25 | 11.87 | 1M |
| 25 September 2026 | 11.92 | 12.04 | 11.42 | 11.62 | 1M |
| 24 September 2026 | 12.46 | 12.48 | 11.51 | 11.80 | 1M |
| 23 September 2026 | 13.30 | 13.45 | 12.25 | 12.54 | 945,200 |
| 22 September 2026 | 12.55 | 13.46 | 12.35 | 13.44 | 805,300 |
| 21 September 2026 | 12.80 | 12.80 | 12.28 | 12.42 | 939,800 |
| 18 September 2026 | 12.53 | 12.61 | 12.25 | 12.56 | 4M |
| 17 September 2026 | 12.55 | 12.82 | 12.43 | 12.55 | 2M |
| 16 September 2026 | 13.00 | 13.15 | 12.18 | 12.23 | 952,000 |
| 15 September 2026 | 13.07 | 13.17 | 12.45 | 12.95 | 1M |
| 14 September 2026 | 12.92 | 13.31 | 12.91 | 13.11 | 1M |